Ocular Surgery News

09/05/2025

The new Clinical Guidance module gives you free access to explore gene therapies and long-acting delivery options in development. https://www.healio.com/clinical-guidance/age-related-macular-degeneration

09/05/2025

How will change AMD treatment? And how will new tools impact the diagnosis and management of disease in ? 👀

Ursula Schmidt-Erfurth, MD, of the Medical University of Vienna, gave the Lecture this year.

Healio

09/05/2025

A great opening ceremony celebrated 25 years of .

Follow along with Healio s upcoming coverage of all the biggest announcements from the Palais des Congrès in Paris!👁️👇

https://www.healio.com/news/ophthalmology/meeting-news/euretina-congress

EURETINA

09/04/2025

A new edition of Eye on Efficiency is right around the corner.👀

Catch up on the debut episode, which covered virtual assistants and the benefits they may provide practices, on Healio:

https://www.healio.com/news/ophthalmology/20250801/eye-on-efficiency-virtual-assistants

Honolulu Eye Clinic

09/04/2025

❗BREAKING❗

VirtuaLens launched the Immersive IOL Simulator, which allows patients to compare IOL options before surgery.

More on Healio:

https://www.healio.com/news/ophthalmology/20250904/virtualens-launches-virtual-realitybased-iol-simulator

VirtuaLens launched the Immersive IOL Simulator, a virtual reality platform designed to compare IOL options before cataract surgery, according to a press release.The platform allows patients to explore monofocal, multifocal and premium IOL options through real-life scenarios, with simulations such a...

09/04/2025

Dr. Dante J. Pieramici on the MAGIC trial:

“The primary endpoint of this trial is going to be the change in area of retinal nonperfusion based on Optos widefield angiography.”

Full video.🔗

https://www.healio.com/news/ophthalmology/20250821/contrast-sensitivity-used-as-endpoint-in-nonproliferative-diabetic-retinopathy-trial
CTS Retina

09/04/2025

💵 The introduces significant changes to the landscape.

In the latest installment of Residency to , OJM GROUP experts highlight the tax provisions they say will be most impactful for physicians.👇

Sweeping tax legislation known as the One Big Beautiful Bill Act, or OBBBA, was signed into law by President Donald J. Trump on July 4, 2025.

09/03/2025

New World Medical launched the Ahmed ClearPath ST, a non-valved drainage device.

Raymond Kong, chief commercial officer, spoke with Healio about the launch.

Find out more. 🔗👇

https://www.healio.com/news/ophthalmology/20250903/new-world-medical-launches-ahmed-clearpath-st-glaucoma-drainage-device

09/03/2025

Read the latest column from Richard L Lindstrom, MD on Healio!

Effective long-term ocular surface management requires to gain knowledge and skill about the art, science and economic realities of treating OSD.👇

https://www.healio.com/news/ophthalmology/20250902/skill-in-art-science-of-ocular-surface-disease-needed-for-successful-treatment

Today, most comprehensive ophthalmologists generate two-thirds of their revenue in the office, twice that in the operating room.In addition, every year, per visit office fees escalate as they are tied to primary care, which is in favor with our government representatives and payers. Finally, by leve...

09/03/2025

👩‍⚕️👨‍⚕️ Support best outcomes for patients with nAMD, DR/DME, and RVO.

Complete this CME on second-generation anti-VEGF therapies today: http://bit.ly/4g4p7ND

09/03/2025

To find success when operating on intumescent white :

⭐Safely decompress the lens.
⭐Achieve a well-controlled capsulorrhexis.
⭐Preserve the integrity of the capsule.

Dr. Uday Devgan MD author of CataractCoach.com breaks it down.👇

https://www.healio.com/news/ophthalmology/20250819/optimal-surgical-approach-to-intumescent-white-cataracts-intraoperative-techniques

09/02/2025

❗BREAKING❗

Nanoscope Therapeutics announced that the granted regenerative medicine advanced therapy designation for MCO-010 for the treatment of .

Find out more on Healio:

The FDA granted regenerative medicine advanced therapy designation for MCO-010 for the treatment of Stargardt disease, according to a press release from Nanoscope Therapeutics.